Science · Open for opinions
Will any major health regulatory agency (FDA, EMA, or WHO) approve a new indication for the Shingrix vaccine specifically for cardiovascular protection by March 2027?
A recent Science News publication indicates that the shingles vaccine (Shingrix) may offer heart protection, sparking debate about… 22 opinions, 50% Yes
- Yes — 50%
- No — 50%
Deadline: March 10, 2027 at 12:00 AM UTC · 22 opinions
Resolution rules
A recent Science News publication indicates that the shingles vaccine (Shingrix) may offer heart protection, sparking debate about possible new clinical indications.
Source: www.sciencenews.org
Frequently asked questions about this event
How is this event resolved?
Resolve como 'Sim' se FDA (EUA), EMA (Europa) ou OMS publicarem, até 10/03/2027, aprovação ou recomendação oficial da vacina Shingrix (zoster recombinante) com indicação explícita de proteção cardiovascular. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now Yes has 50% of the votes: an opinion on it that turns out right earns about 50 points, a wrong one costs about 50.